page contents

Tag Archives: reiterated

BLUCORA INC Common Stock (NASDAQ:BCOR) had its Buy rating reiterated by Barrington Research with a $41.00 price target

BLUCORA INC Common Stock (NASDAQ:BCOR) had its Buy rating reiterated by Barrington Research with a $ 41.00 price target Mar 20, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For BLUCORA INC Common Stock (NASDAQ:BCOR) Today, Barrington Research reiterated its Buy rating on BLUCORA INC Common Stock (NASDAQ:BCOR) with a price target of $ 41.00. There are 5 Buy Ratings, ...

Read More »

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $16.00 price target

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $ 16.00 price target Mar 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Fennec Pharmaceuticals Inc (NASDAQ:FENC) Today, Wedbush reiterated its Outperform rating on Fennec Pharmaceuticals Inc (NASDAQ:FENC) with a price target of $ 16.00. There are 4 Buy Ratings, no Strong Buy Ratings, no ...

Read More »

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $16.00 price target

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $ 16.00 price target Mar 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Fennec Pharmaceuticals Inc (NASDAQ:FENC) Today, Wedbush reiterated its Outperform rating on Fennec Pharmaceuticals Inc (NASDAQ:FENC) with a price target of $ 16.00. There are 4 Buy Ratings, no Strong Buy Ratings, no ...

Read More »

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $16.00 price target

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $ 16.00 price target Mar 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Fennec Pharmaceuticals Inc (NASDAQ:FENC) Today, Wedbush reiterated its Outperform rating on Fennec Pharmaceuticals Inc (NASDAQ:FENC) with a price target of $ 16.00. There are 4 Buy Ratings, no Strong Buy Ratings, no ...

Read More »

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $16.00 price target

Fennec Pharmaceuticals Inc (NASDAQ:FENC) had its Outperform rating reiterated by Wedbush with a $ 16.00 price target Mar 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Fennec Pharmaceuticals Inc (NASDAQ:FENC) Today, Wedbush reiterated its Outperform rating on Fennec Pharmaceuticals Inc (NASDAQ:FENC) with a price target of $ 16.00. There are 4 Buy Ratings, no Strong Buy Ratings, no ...

Read More »

BMC Stock Holdings Inc (NASDAQ:BMCH) had its Outperform rating reiterated by Wedbush with a $23.00 price target

BMC Stock Holdings Inc (NASDAQ:BMCH) had its Outperform rating reiterated by Wedbush with a $ 23.00 price target Mar 12, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For BMC Stock Holdings Inc (NASDAQ:BMCH) Today, Wedbush reiterated its Outperform rating on BMC Stock Holdings Inc (NASDAQ:BMCH) with a price target of $ 23.00. There are 9 Hold Ratings, 4 Buy ...

Read More »

Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wedbush with a $217.00 price target

Ascendis Pharma A/S (NASDAQ:ASND) had its Outperform rating reiterated by Wedbush with a $ 217.00 price target Mar 07, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND) Today, Wedbush reiterated its Outperform rating on Ascendis Pharma A/S (NASDAQ:ASND) with a price target of $ 217.00. There are 8 Buy Ratings, no Strong Buy Ratings, no ...

Read More »

Ambarella (NASDAQ:AMBA) had its Buy rating reiterated by Northland Securities

Ambarella (NASDAQ:AMBA) had its Buy rating reiterated by Northland Securities Mar 06, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Ambarella (NASDAQ:AMBA) Today, Northland Securities reiterated its Buy rating on Ambarella (NASDAQ:AMBA). There are 6 Buy Ratings, 5 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock. The current consensus rating on Ambarella (NASDAQ:AMBA) is Hold ...

Read More »

AnaptysBio Inc (NASDAQ:ANAB) had its Buy rating reiterated by Cantor Fitzgerald with a $140.00 price target

AnaptysBio Inc (NASDAQ:ANAB) had its Buy rating reiterated by Cantor Fitzgerald with a $ 140.00 price target Feb 27, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For AnaptysBio Inc (NASDAQ:ANAB) Today, Cantor Fitzgerald reiterated its Buy rating on AnaptysBio Inc (NASDAQ:ANAB) with a price target of $ 140.00. There are 10 Buy Ratings, 1 Hold Ratings, no Strong Buy ...

Read More »

Aerie Pharmaceuticals Inc (NASDAQ:AERI) had its Buy rating reiterated by Cowen

Aerie Pharmaceuticals Inc (NASDAQ:AERI) had its Buy rating reiterated by Cowen Feb 27, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Aerie Pharmaceuticals Inc (NASDAQ:AERI) Today, Cowen reiterated its Buy rating on Aerie Pharmaceuticals Inc (NASDAQ:AERI). There are 10 Buy Ratings, 1 Sell Ratings, no Strong Buy Ratings, no Hold Ratings on the stock. The current consensus rating on ...

Read More »

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close